Neuromuscular Block and Anesthetic Depth Monitoring

Not Applicable

Completed

• Conditions: Cholecystectomy, Laparoscopic
• Interventions: Drug: Rocuronium (MB group); Drug: Rocuronium (DB group)

• Registration Number: NCT02575443
• Lead Sponsor: Seoul National University Bundang Hospital

Brief Summary

The purpose of this study is to evaluated whether the depth of neuromuscular block may affect the unicon value of anesthetic depth monitoring system (ADMS).

Detailed Description

Not available

Study Timeline

• Study Start: 2015-09
• Study First Submitted: 2015-10-06
• Study First Submitted QC: 2015-10-09
• Study First Posted: 2015-10-14
• Primary Completion: 2017-09
• Study Completion: 2017-09
• Status Verified: 2018-10
• Last Update Submitted: 2018-10-24
• Last Update Posted: 2018-10-26

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

• Gall bladder disease
• American Society of Anesthesiologist physical status 1 or 2

Read More

Exclusion Criteria

• Pregnancy
• Body mass index < 16
• Body mass index >30
• Neuromuscular disease
• Previous intraabdominal surgery

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Moderate block (MB) group	Rocuronium (MB group)	-
Deep block (DB) group	Rocuronium (DB group)	-

Primary Outcome Measures

Name	Time	Method
Total infused dose of propofol	At 1 min after the anesthesia is finished

Secondary Outcome Measures

Name	Time	Method
Electromyographic index presented on the anesthetic depth monitoring system	Through study completion, an average of 2 hours

Trial Locations

Locations (1)

Seoul National University Bundang Hospital; 🇰🇷 Seongnam, Gyeonggi, Korea, Republic of